Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial

Eur Heart J. 2024 Dec 6:ehae864. doi: 10.1093/eurheartj/ehae864. Online ahead of print.
No abstract available

Keywords: Anaemia; Empagliflozin; Erythrocytosis; Heart failure with preserved ejection fraction.